In this study, we demonstrated the anti-angiogenic effects of sMEK1 using in vitro human umbilical vein endothelial cells (HUVECs) and SKOV-3 ovarian cancer cells, and in vivo mouse model systems. This evidence concerns the gene PPP4R3A and ovarian carcinoma.